Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein‐Barr virus (EBV) infection

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Transplant International

• Publication date

  2000-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1432-2277.2000.tb02070.xPMID 11112042
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Hepatitis C virus infection in patients with non Hodgkin's lymphoma].

  2001cited by this paper
• In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype.

  1998cited by this paper
• High prevalence of hepatitis C virus infection in patients with B‐cell lymphoproliferative disorders in Italy

  1997cited by this paper
• The clinical diversity and role of chemotherapy in lymphoproliferative disorder in liver transplant recipients.

  1997cited by this paper
• Hepatitis C virus infection and clonal B-cell expansion.

  1996cited by this paper
• Extrahepatic manifestations of hepatitis C.

  1996cited by this paper
• Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?

  1996cited by this paper
• Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders

  1995cited by this paper
• De novo solid malignancies after cardiac transplantation.

  1995cited by this paper
• Epstein-Barr viral infection and posttransplantation lymphoproliferative disorders.

  1995cited by this paper
• Clonal B‐cell expansions in peripheral blood of HCV‐infected patients

  1995cited by this paper
• Hepatitis C: A Multifaceted Disease: Review of Extrahepatic Manifestations

  1995cited by this paper
• Epstein-Barr viral infection and posttransplantation lymphoproliferative disorders.

  1995cited by this paper
• Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.

  1995cited by this paper
• Hepatitis C virus infection in patients with non‐Hodgkin's lymphoma

  1994cited by this paper
• Tumors after renal and cardiac transplantation.

  1993cited by this paper
• A role for hepatitis C virus infection in type II cryoglobulinemia.

  1992cited by this paper
• Detection of Epstein-Barr virus by polymerase chain reaction

  1990cited by this paper
• An Immunocytochemical Technique Offering Increased Sensitivity and Lowered Cost with a Streptavidin-Horseradish Peroxidase Conjugate

  1989cited by this paper
• INCREASED FREQUENCY OF POSTTRANSPLANT LYMPHOMAS IN PATIENTS TREATED WITH CYCLOSPORINE, AZATHIOPRINE, AND PREDNISONE

  1989cited by this paper
• Increased frequency of posttransplant lymphomas in patients treated with cyclosporin, azathioprine, and prednisone.

  1989cited by this paper
• THE FREQUENCY OF EPSTEIN‐BARR VIRUS INFECTION AND ASSOCIATED LYMPHOPROLIFERATIVE SYNDROME AFTER TRANSPLANTATION AND ITS MANIFESTATIONS IN CHILDREN

  1988cited by this paper
• Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

  1984cited by this paper
• Malignant lymphomas in organ transplant recipients.

  1981cited by this paper

• Belatacept in Solid Organ Transplantation: Current Kidney Applications, Future Perspectives in Other Organs, and Clinical Implications.

  2026cites this paper
• Outcomes and Prognostic Assessment of Post-Transplant Lymphoproliferative Disorder: 20-Year Experience

  2025cites this paper
• A Pathology Experience of Posttransplant Lymphoproliferative Disorder From One Tertiary Hospital: Pathology Concepts and Diagnostic Approach

  2024cites this paper
• Results of Two Cases of Pig-to-Human Kidney Xenotransplantation.

  2022cites this paper
• Heterogeneous Manifestations of Posttransplant Lymphoma in Renal Transplant Recipients: A Case Series.

  2021cites this paper
• Malignancy After Transplant

  2020cites this paper
• Post-Transplant Lymphoproliferative Disorders Arising after Allogeneic Hematopoietic Cell Transplantation: A Comprehensive Review

  2020cites this paper
• Aggressive Epstein‐Barr virus‐negative B‐cell post‐transplant lymphoproliferative disorder in a hepatitis C‐negative liver transplant recipient who received a hepatitis C‐positive graft: Implications for D+/R− hepatitis C virus seroconversion

  2019cites this paper
• Isolated peritoneal lymphomatosis defined as post-transplant lymphoproliferative disorder after a liver transplant: A case report

  2019cites this paper
• Colorectal Cancer Characteristics and Outcomes after Solid Organ Transplantation

  2018cites this paper
• Very late onset post-transplant diffuse large B cell lymphoma in a liver transplant recipient with hepatitis B

  2018cites this paper
• Late Complications Following Heart Transplant

  2017cites this paper
• Long-Term Outcome of Renal Insufficiency in Children

  2016cites this paper
• Matched-pair analysis: identification of factors with independent influence on the development of PTLD after kidney or liver transplantation

  2016cites this paper
• Lymphoproliférations survenant après transplantation d’organes solides

  2016cites this paper
• B-cell Lymphoproliferative Disorders Associated with Primary and Acquired Immunodeficiency.

  2016cites this paper
• Post-transplant lymphoproliferative disorders.

  2015cites this paper
• Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies

  2013cites this paper
• disorder among solid organ transplant recipients Hepatitis C virus infection and risk of post-transplant lymphoproliferative

  2013cites this paper
• Plasmablastic Lymphoma Following Transplantation

  2013cites this paper
• Malignancies After Liver Transplantation: A Review Of The Literature

  2012cites this paper
• The Impact of De novo Tumors after Liver Transplantation on Long Term Survival

  2012cites this paper
• Post Transplant Lymphoproliferative Disorders: Risk, Classification, and Therapeutic Recommendations

  2012cites this paper
• Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders

  2011cites this paper
• Surveillance of epstein‐barr virus loads in adult liver transplantation: Associations with age, sex, posttransplant times, and transplant indications

  2011cites this paper
• Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries.

  2010cites this paper
• Syndromes lymphoprolifératifs après transplantation rénale : incidence et particularités cliniques et évolutives

  2008cites this paper
• CHAPTER 63 – Malignancy after Pediatric Renal Transplantation

  2008cites this paper
• Oral posttransplantation lymphoproliferative disorder: an uncommon site for an uncommon disorder.

  2008cites this paper
• Complications hématologiques malignes, en particulier lymphoprolifératives, après transplantation

  2008cites this paper
• Posttransplant lymphoproliferative disorders.

  2008cites this paper
• Transplantation: Posttransplant Lymphoproliferative Disorder

  2007cites this paper
• Hepatitis C virus infection and risk of post-transplant lymphoproliferative disorder among solid organ transplant recipients

  2007cites this paper
• Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients.

  2007cites this paper
• The clinicopathologic spectrum of posttransplantation lymphoproliferative disorders.

  2007cites this paper
• Hepatitis C virus related lymphoproliferative disorder in a renal transplant recipient

  2006cites this paper
• Review of Epstein–Barr virus and post‐transplant lymphoproliferative disorder post‐solid organ transplantation (Review Article)

  2006cites this paper
• Post-transplantation lymphoproliferative disorder in pediatric patient

  2006cites this paper
• [Hematologic malignant complications after transplantation].

  2006cites this paper
• Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?

  2006cites this paper
• Post‐Transplant Lymphoproliferative Disorders Occurring After Renal Transplantation in Adults: Report of 230 Cases From the French Registry

  2006cites this paper
• Post-transplantation lymphoproliferative disorder in pediatric patient.

  2006cites this paper
• Can donors with prior hepatitis be safely used for heart transplantation?

  2006cites this paper
• Posttransplant Lymphoproliferative Disorders after Renal Transplantation in the United States in Era of Modern Immunosuppression

  2005cites this paper
• Post-transplant lymphoproliferative disorder in children: incidence, prognosis, and treatment options.

  2005cites this paper
• Characterization of Anti-Myosin Monoclonal Antibodies

  2005cites this paper
• Post-Transplant Lymphoproliferative Disorder in Children

  2005cites this paper
• Incidence of cancer after immunosuppressive treatment for heart transplantation.

  2005cites this paper
• The post-transplant lymphoproliferative disorder—a literature review

  2004cites this paper
• Prevention and treatment of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants: a review

  2003cites this paper
• Infections in the heart transplant recipient.

  2003cites this paper
• Hepatitis C in the setting of kidney, heart, lung, and bone marrow transplants

  2003influential citation
• T cell immunodeficiency and severe herpes virus infections after allogeneic stem cell transplantation

  2003cites this paper
• Prevention and treatment of epstein–barr virus‐associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants

  2002cites this paper
• De novo noncutaneous malignancies in heart transplantation: a single-centre 15-year experience and risk factor analysis.

  2001cites this paper
• De novo malignancies after liver transplantation: A major cause of late death

  2001cites this paper
• Malignant neoplastic disorders following long-term immunosuppression after orthotopic heart transplantation.

  2001cites this paper
• Clinical practice guidelines.

  1999cites this paper
• on the quality of life of liver transplant recipients

  year unknowncites this paper